Physician Wealth Advisors’s MBX Biosciences MBX Stock Holding History

Physician Wealth Advisors’s Portfolio MBX Stock Details MBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.09K	Hold	121	–	–	﹤0.01%	1007
2026 Q2	$6.68K	Buy	121 +12	+11%	+$419	﹤0.01%	992
2026 Q1	$3.25K	Hold	109	–	–	﹤0.01%	1147
2025 Q4	$3.44K	Hold	109	–	–	﹤0.01%	1089
2025 Q3	$1.91K	Hold	109	–	–	﹤0.01%	1250
2025 Q2	$1.24K	Buy	+109	New	+$1.11K	﹤0.01%	1253

Other funds holding MBX

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

Sowell Financial Services North Little Rock, Arkansas $3.12B AUM 22.73% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

Koa Wealth Management Encinitas, California $154M AUM 13.16% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Physician Wealth Advisors's MBX Position: Q3 2026 in Review

Physician Wealth Advisors held its MBX Biosciences (MBX) position steady in Q3 2026 at 121 shares worth $7.09K. The position accounts for ﹤0.01% of the portfolio, ranked #1007.

Physician Wealth Advisors first reported a position in MBX in Q2 2025 and has held it in 6 quarters since. 32 funds tracked by Wall St. Rank hold MBX as of Q3 2026.

Physician Wealth Advisors held 121 shares of MBX Biosciences worth $7.09K as of Q3 2026.
Physician Wealth Advisors left its MBX Biosciences share count unchanged in Q3 2026.
MBX Biosciences made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #1007 holding.
Physician Wealth Advisors first reported a position in MBX Biosciences in Q2 2025 and has held it in 6 quarters since.
32 funds tracked by Wall St. Rank held MBX Biosciences as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.